Search research articles
Contact Us
Filters
Showing results (41-50 of 201) with videos related to
Page
of 21
Sort By:
Gynecologic Oncology
|
July 31, 2007
Avoiding bevacizumab related gastrointestinal toxicity for recurrent ovarian cancer by careful patient screening
Fiona Simpkins, Jerome L Belinson, Peter G Rose
Gynecology & Obstetrics (Sunnyvale, Calif.)
|
December 20, 2021
To PARPI or Not to PARPI BRCA Mutated Ovarian Cancer Following First-line Chemotherapy, That is the Question?
Peter G Rose, Laura M Chambers, Michelle Kuznicki
Gynecologic Oncology
|
February 27, 2010
Assessment of tumor response as a surrogate endpoint of survival in recurrent/platinum-resistant ovarian carcinoma: a Gynecologic Oncology Group study
Peter G Rose, Chunqiao Tian, Michael A Bookman
Gynecologic Oncology
|
December 13, 2002
Arterial thrombosis in a gynecologic oncology patient: evaluation and management
Andrew E Green, Keith McCrae, Peter G Rose
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 13, 2015
Epithelial Ovarian Cancer Metastatic to the Central Nervous System and a Family History Concerning for Hereditary Breast and Ovarian Cancer--A Potential Relationship
Amelia M Jernigan, Haider Mahdi, Peter G Rose
Gynecologic Oncology
|
September 11, 2009
Pulmonary hypertension in two patients treated with bevacizumab for recurrent ovarian cancer
Margaret Liotta, Peter G Rose, Pedro F Escobar
Gynecologic Oncology Reports
|
October 12, 2017
Adverse post-operative outcomes in Jehovah's witnesses with gynecologic cancer within 30 days of surgery: A single institution review of 36 cases
Laura J Moulton, Peter G Rose, Haider Mahdi
Gynecologic Oncology
|
August 11, 2007
A phase I study of gemcitabine followed by cisplatin concurrent with whole pelvic radiation therapy in locally advanced cervical cancer: a Gynecologic Oncology Group study
Peter G Rose, Koen Degeest, Scott McMeekin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 4, 2016
Activity of Bevacizumab in Patients With Low-Grade Serous Ovarian Carcinoma
Peter G Rose, Haider Mahdi, Amelia Jernigan, et al.
American Journal of Obstetrics and Gynecology
|
November 6, 2007
Symptomatic vaginal bleeding in a postmenopausal woman: a case report of pancreatic adenocarcinoma metastasizing exclusively to the vagina
Amanda Nickles Fader, Jennifer A Brainard, Peter G Rose
Page
of 21
Search research articles
Search
Showing results (41-50 of 201) with videos related to
Sort By:
Page
of 21
Gynecologic Oncology
|
July 31, 2007
Avoiding bevacizumab related gastrointestinal toxicity for recurrent ovarian cancer by careful patient screening
Fiona Simpkins, Jerome L Belinson, Peter G Rose
Gynecology & Obstetrics (Sunnyvale, Calif.)
|
December 20, 2021
To PARPI or Not to PARPI BRCA Mutated Ovarian Cancer Following First-line Chemotherapy, That is the Question?
Peter G Rose, Laura M Chambers, Michelle Kuznicki
Gynecologic Oncology
|
February 27, 2010
Assessment of tumor response as a surrogate endpoint of survival in recurrent/platinum-resistant ovarian carcinoma: a Gynecologic Oncology Group study
Peter G Rose, Chunqiao Tian, Michael A Bookman
Gynecologic Oncology
|
December 13, 2002
Arterial thrombosis in a gynecologic oncology patient: evaluation and management
Andrew E Green, Keith McCrae, Peter G Rose
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 13, 2015
Epithelial Ovarian Cancer Metastatic to the Central Nervous System and a Family History Concerning for Hereditary Breast and Ovarian Cancer--A Potential Relationship
Amelia M Jernigan, Haider Mahdi, Peter G Rose
Gynecologic Oncology
|
September 11, 2009
Pulmonary hypertension in two patients treated with bevacizumab for recurrent ovarian cancer
Margaret Liotta, Peter G Rose, Pedro F Escobar
Gynecologic Oncology Reports
|
October 12, 2017
Adverse post-operative outcomes in Jehovah's witnesses with gynecologic cancer within 30 days of surgery: A single institution review of 36 cases
Laura J Moulton, Peter G Rose, Haider Mahdi
Gynecologic Oncology
|
August 11, 2007
A phase I study of gemcitabine followed by cisplatin concurrent with whole pelvic radiation therapy in locally advanced cervical cancer: a Gynecologic Oncology Group study
Peter G Rose, Koen Degeest, Scott McMeekin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 4, 2016
Activity of Bevacizumab in Patients With Low-Grade Serous Ovarian Carcinoma
Peter G Rose, Haider Mahdi, Amelia Jernigan, et al.
American Journal of Obstetrics and Gynecology
|
November 6, 2007
Symptomatic vaginal bleeding in a postmenopausal woman: a case report of pancreatic adenocarcinoma metastasizing exclusively to the vagina
Amanda Nickles Fader, Jennifer A Brainard, Peter G Rose
Page
of 21